Ageing guts lose diversity — but cause is still unproven

Population ageing has sharpened interest in the biological mechanisms that shape healthspan and vulnerability to age-related disease. The gut microbiota is one candidate, because it modulates immune, metabolic and neurophysiological processes that all shift with age. If the microbial community changes in predictable ways as people get older, and if those changes feed the chronic low-grade inflammation often called inflammaging, then the gut becomes a plausible target for keeping people healthier for longer. This review set out to ask how solid that chain of reasoning actually is in humans.

The authors ran a narrative literature search across PubMed, Scopus and Web of Science, covering peer-reviewed work published between 2010 and 2025. They prioritised human evidence: observational studies, longitudinal cohorts, mechanistic investigations and interventional trials, with particular attention to older adults, frailty, longevity and microbiota-mediated mechanisms of ageing biology. Studies of centenarians were included alongside trials of dietary and lifestyle interventions. Because this is a narrative synthesis rather than a systematic review, no pooled statistics, risk-of-bias scoring or formal certainty grading were reported.

The recurring pattern across studies was lower microbial diversity with age, depletion of beneficial short-chain fatty acid-producing taxa, altered intestinal barrier integrity and a greater abundance of pro-inflammatory microorganisms. These features were linked to inflammaging and, in turn, to neurodegenerative, cardiovascular, metabolic, musculoskeletal and joint conditions including osteoporosis, sarcopenia, rheumatoid arthritis and osteoarthritis. Work on centenarians suggested that preserving specific microbial metabolic functions may track with healthier ageing trajectories. Crucially, the review flags that causality is incompletely established in humans and that inter-individual variability is substantial. Mediterranean-style diets rich in fibre and polyphenols, exercise, prebiotics and probiotics were described as showing potential to modulate these pathways.

The synthesis sits comfortably within the existing inflammaging and hallmarks-of-ageing framework, and it does not overturn anything: it consolidates a large but largely correlational human literature. What it does not do is settle direction of effect — an older, less diverse microbiome could be a driver of decline, a consequence of it, or a marker of diet, medication and frailty. The authors also name reproducibility, standardisation of microbiome analyses and personalised implementation as unresolved problems, and call for longitudinal multi-omics studies and precision interventions to close the gap.

This is a reason to treat the gut microbiome as a promising but immature target rather than a settled lever on ageing. The dietary and lifestyle patterns highlighted here — fibre-rich, polyphenol-rich Mediterranean-style eating and regular physical activity — are already supported for other reasons, so the microbiome story adds a plausible mechanism rather than a new instruction. Claims that a specific product can rejuvenate an ageing microbiome run well ahead of the evidence this review describes. Expect the personalised end of this field to remain exploratory for some time.